Viewing StudyNCT00513669



Ignite Creation Date: 2024-05-05 @ 6:36 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00513669
Status: COMPLETED
Last Update Posted: 2013-03-15
First Post: 2007-08-08

Brief Title: Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components PEV 301 PEV 302 in Tanzania
Sponsor: Swiss Tropical Public Health Institute
Organization: Swiss Tropical Public Health Institute

Organization Data

Organization: Swiss Tropical Public Health Institute
Class: OTHER
Study ID: PMAL03
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Swiss Tropical Public Health Institute
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Pevion Biotech Ltd INDUSTRY
Mymetics Corporation INDUSTRY